TC Medical(SH:600763)2015-04-23 16:00Financial Performance - Net profit attributable to shareholders increased by 26.38% to CNY 31,438,448.46 year-on-year[7] - Operating revenue rose by 23.09% to CNY 149,080,553.56 compared to the same period last year[7] - Basic earnings per share increased by 25.00% to CNY 0.20 compared to the same period last year[7] - Net profit excluding non-recurring gains and losses increased by 49.89% to CNY 29,624,117.99 year-on-year[7] - Total revenue for Q1 2015 was CNY 149,080,553.56, an increase of 23.2% compared to CNY 121,115,528.92 in the same period last year[31] - Net profit for Q1 2015 reached CNY 32,097,650.81, representing a 23.5% increase from CNY 25,999,826.74 in Q1 2014[32] - Earnings per share for Q1 2015 were CNY 0.20, compared to CNY 0.16 in the same quarter last year, reflecting a 25% increase[33] - The company reported a total comprehensive income of CNY 350,390.85 for the quarter, compared to CNY 161,805.52 in the same period last year[36] Cash Flow - Net cash flow from operating activities surged by 1391.89% to CNY 15,047,728.09 year-to-date[7] - Cash inflow from operating activities totaled CNY 155,598,045.13, down from CNY 191,719,065.44 in the previous year, reflecting a decrease of approximately 18.9%[39] - The net cash flow from operating activities was CNY 15,047,728.09, a substantial increase from CNY 1,008,637.60 in Q1 2014[39] - The cash flow from financing activities showed a net increase of CNY 4,900,000.00, indicating successful capital raising efforts[40] Assets and Liabilities - Total assets increased by 2.69% to CNY 814,485,659.66 compared to the end of the previous year[7] - Accounts receivable increased by 42.89% to ¥10,768,407.33 due to an increase in medical insurance settlement receivables[14] - Other current assets rose by 110.87% to ¥2,183,922.20 primarily due to an increase in the balance of taxes payable[14] - The company's total liabilities decreased to RMB 91,073,546.43 from RMB 106,734,929.94, a reduction of approximately 14.7%[26] - The total equity attributable to the parent company increased to RMB 661,041,332.99 from RMB 629,602,884.51, reflecting a growth of about 5%[26] Investments and Expansion Plans - The company plans to establish a joint venture, Chongqing Boen Reproductive Hospital, with a 51% stake from a health management company and 49% from Chongqing Research Institute[14] - The company plans to invest ¥650,000 to establish Zhengzhou Dental Hospital Investment Co., holding a 65% stake[17] - The company is in the process of setting up multiple dental hospitals, including a children's dental chain and various regional branches, with total registered capital of ¥1,000,000 for each[19][20][21] - The company plans to establish a new dental hospital in Hangzhou with a registered capital of RMB 6 million, where the company will contribute RMB 3.6 million, holding a 60% stake[22] Shareholder Information - The total number of shareholders reached 7,428 at the end of the reporting period[12] - The largest shareholder, Hangzhou Baoqun Industrial Group Co., Ltd., holds 33.75% of the shares[12] Other Financial Metrics - The weighted average return on equity improved by 0.19 percentage points to 4.87%[7] - Financial expenses decreased significantly by 657.18% to -¥968,642.16, primarily due to increased interest income from deposits[17] - Investment income dropped by 80.51% to ¥316,124.58, mainly due to gains from the transfer of subsidiaries in the previous year[17] - Operating costs for Q1 2015 amounted to CNY 109,586,535.46, up 19.2% from CNY 91,910,580.96 in Q1 2014[32] - The company reported a gross profit of CNY 39,494,018.10 for Q1 2015, up from CNY 29,204,947.96 in Q1 2014, indicating a gross margin improvement[31]